Disclosed herein is the use of phytol and/or phytanic acid in the manufacture of a medicament for the prophylaxis, prevention and/or treatment of hypercholesterolemia, in subjects with elevated serum levels of LDL cholesterol, wherein the prophylaxis, prevention and/or treatment will lead to selective reduction in serum levels of LDL cholesterol as compared to serum levels of HDL cholesterol.